| |
| |
 |
 |
| Transgene's current products can be categorized under 4 main technology platforms. The 1st is Bio-Generic Drugs, which includes Orlistat, Tacrolimus and recombinant Erythropoietin. The 2nd is a Novel Drug Delivery Technology for the oral delivery of protein drugs, with the first two targets being Insulin and Hep B vaccine. The 3rd is a new platform for drugs against auto-immune diseases, and is currently targeting HIV and Multiple Sclerosis. The final category is Oncology drugs encompassing both RNAi technology as well as monoclonal antibodies. |
|
 |
 |
|
| |
» Know More |
|
|
|
|
|
| |
| |
 |
|
| Since 1994, Transgene Biotek has developed or has been involved in the development of technology for several different bio-pharmaceuticals, recombinant vaccines and therapeutics. We have extensive experience and expertise to assist you in recombinant drug development, characterization, testing and validation. |
|
 |
|
| Transgene can fulfil your needs for recombinant DNA constructs. We can take care of the initial cloning of your gene of interest and take it all the way through to the development of multiple constructs. |
|
| |
|
» Know More |
|
|
| |
|
|
